Pharmaceuticals News and Research

RSS
Repligen total revenue increases 30% to $27,291,000 for fiscal year 2011

Repligen total revenue increases 30% to $27,291,000 for fiscal year 2011

JDRF, Selecta Biosciences partner to develop type 1 diabetes vaccine

JDRF, Selecta Biosciences partner to develop type 1 diabetes vaccine

UAB acquires first cell-processing workstation from SANYO

UAB acquires first cell-processing workstation from SANYO

Eight out of 10 countries using mHealth services, WHO report says

Eight out of 10 countries using mHealth services, WHO report says

Eli Lilly receives favorable U.S. District Court ruling in Amylin litigation

Eli Lilly receives favorable U.S. District Court ruling in Amylin litigation

FDA accepts Adamis IND for APC-100 to treat prostate cancer

FDA accepts Adamis IND for APC-100 to treat prostate cancer

Isotechnika reports consolidated net loss of $2.9 million for first quarter 2011

Isotechnika reports consolidated net loss of $2.9 million for first quarter 2011

UAB first in U.S. with cell-processing workstation

UAB first in U.S. with cell-processing workstation

Paladin to commercialize Silenor for treatment of insomnia in Canada, South America and Africa

Paladin to commercialize Silenor for treatment of insomnia in Canada, South America and Africa

Grifols officially merges with Talecris Biotherapeutics

Grifols officially merges with Talecris Biotherapeutics

Positive results from RXi's NeuVax-trastuzumab Phase 2 trial on breast cancer presented at ASCO

Positive results from RXi's NeuVax-trastuzumab Phase 2 trial on breast cancer presented at ASCO

Novation recognizes APP with NOVAPLUS Pharmacy Manufacturer of the Year

Novation recognizes APP with NOVAPLUS Pharmacy Manufacturer of the Year

Scientists find neuronal cells die in Alzheimer's disease

Scientists find neuronal cells die in Alzheimer's disease

Millennium reports results from two VELCADE based combination studies against multiple myeloma

Millennium reports results from two VELCADE based combination studies against multiple myeloma

GAVI appeals for $3.7B ahead of pledging conference despite lower vaccine prices

GAVI appeals for $3.7B ahead of pledging conference despite lower vaccine prices

Self-assembling mini devices now enlisted in nanomedicine revolution

Self-assembling mini devices now enlisted in nanomedicine revolution

Quest conducts first clinical Investigators Meeting for Oregovomab in Rome, provides corporate updates

Quest conducts first clinical Investigators Meeting for Oregovomab in Rome, provides corporate updates

Scientists discover four different bacteria that can live on caffeine

Scientists discover four different bacteria that can live on caffeine

McGill researcher develops speedier technique for predicting protein folding pathways

McGill researcher develops speedier technique for predicting protein folding pathways

FDA grants orphan drug designation for Edison's EPI-743 to treat inherited mitochondrial diseases

FDA grants orphan drug designation for Edison's EPI-743 to treat inherited mitochondrial diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.